)
TELA Bio (TELA) investor relations material
TELA Bio Canaccord Genuity’s 45th Annual Growth Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Market trends and company positioning
Hernia repair is shifting from permanent synthetic mesh to non-permanent, natural repair solutions, with robotic procedures expected to reach 80% of all hernia repairs in the future.
Plastic and reconstructive surgery is moving away from cadaver skin due to cost and performance, creating demand for novel materials.
The company is well positioned in both markets, with a broad product portfolio and strong clinical data supporting low recurrence rates.
Over 73,000 implantations and 40+ publications demonstrate clinical success and market penetration.
International revenue now accounts for 15%, with growth opportunities in the UK and Europe as regulatory filings progress.
Commercial strategy and leadership
A new commercial leadership team with experience scaling businesses has been onboarded, focusing on expanding sales and market access.
The sales force is supported by strategic account teams and a succession plan, with a focus on both GPO and IDN contracting.
The company is executing an RTM (Reinforced Tissue Matrix) exit plan to create a unique product category and avoid corporate bundling, with 25 RTM contracts already secured.
Sales territories are being optimized, with additional reps added in high-potential cities and a six-month breakeven target for new hires.
The sales approach is shifting from transactional to patient-centric, emphasizing clinical value and mission-driven messaging.
Medical education and clinical development
A strong medical education team is in place, led by an executive who also oversees clinical programs and KOL relationships.
The focus is on expanding presence in teaching hospitals and engaging young attendings who are more receptive to new technologies.
Medical education events will shift from cadaver labs to more cost-effective didactic sessions.
No additional capital is required for these initiatives; resources will be reallocated within existing budgets.
Published clinical data is robust, supporting both hernia and PRS product lines and driving adoption.
Next TELA Bio earnings date
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)